Ludmilla Aristilde

And now it's everywhere.

Right.

Because we've invested in it and we made them we've made improvements and it's become something that is now well accepted societally.

And now we use it everywhere.

And I would

Imagine that this part of the solution, not the whole solution, but this part of the solution that's so attractive, that could actually provide some avenue that other solutions do not provide.

If we make the proper investment, it could lead to really good dividends on the other end.

Yeah, that's a very good question.

Because I'm studying the natural ability, and so I'm studying the bacteria that already have, like they're in the environment to begin with.

But definitely, if we are engineering bacteria and we are putting new genes, I mean, in this case, if we're putting harmful genes, for example, or harmful pathways, we should think about containment.

And as I mentioned earlier, if you use bioreactors when this is not something we're just releasing in the wild, I'd like to point out that I don't believe just using this bacteria and putting it in the wild is going to work as well as it works when we have just one species of bacteria that is working on this.

Because in the wild, they won't have to compete with other microbes.

Yeah.

And two, in the wild, we have other yummier food than the plastics for the microbes to eat.

Yeah, scale is a challenge to be able to have that, the phenotype.

So essentially to have, let's say, I know I have this bacterium, I know it can do what I want it to do.

Now, can I engineer it to have

a certain behavior, let's say, you know, to break the polymer better or to make another product.

How can I have that sustain over multiple generations of this bacteria?

And rightly so, the scalability of